Research and Markets: Concise Analysis of the International Pain Therapeutics Market - Updated 2014 Report

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/mzdfcp/pain_therapeutics) has announced the addition of a new report "Concise Analysis of the International Pain Therapeutics Market - Updated 2014 Report" to their offering.

"Concise Analysis of the International Pain Therapeutics Market - Updated 2014 Report", describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic pain and cancer pain. Because pain is a subjective sensation, it is difficult to evaluate objectively in clinical trials. Various tools for pain measurement are described, including brain imaging. Most of the currently used analgesic drugs fall into the categories of opioids and nonsteroidal antiinflammatory drugs such as COX-2 inhibitors.

Non-opioid analgesics include ketamine, a N-methyl-D-aspartate receptor antagonist. Adjuvant analgesics include antidepressants and antiepileptic drugs used for the treatment of neuropathic pain. Management of pain is multidisciplinary and includes both pharmacological and non-pharmacological methods such as acupuncture, transcutaneous electrical nerve stimulation and surgery. Various pain syndromes require different approaches in management, for example, the main category of drugs for migraine are triptans such as sumatriptan.

Over 500 companies have been identified to be involved in developing or marketing pain therapeutics and 169 of these are profiled in the report along with 148 collaborations. These are a mix of pharmaceutical companies and biotechnology companies.

The worldwide analgesic markets were analyzed for the year 2013 and projected to 2023. Calculations are based on the epidemiology of various painful conditions and the development of analgesic drugs and devices. Unfulfilled needs for analgesics are identified and strategies are outlined to develop markets for analgesic drugs.

Key Topics Covered:

Executive Summary

1. Basic Aspects of Pain

2. Assessment of Pain and Analgesics

3. Pharmacotherapy of Pain

4. Management of Pain

5. Drug Delivery for Pain

6. Drug Development for Pain

7. Legal and regulatory issues of pain management

8. Pain Markets

9. Future of Pain Therapeutics

10. Companies Involved in Pain Therapeutics

11. References

For more information visit http://www.researchandmarkets.com/research/mzdfcp/pain_therapeutics

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals